Anti-MDA5 antibodies are detected in 30-50% of dermatomyositis-associated ILD cases, often presenting as clinically amyopathic dermatomyositis with minimal muscle involvement but rapidly progressive lung injury [6-8]. This evidence concerns the gene IFIH1 and dermatomyositis.